ClinicalTrials.gg
Sign In

Binge-Eating Disorder clinical trials

The registry lists 233 studies for Binge-Eating Disorder across more than 10 countries. 53 are recruiting or about to start. 129 of them are mainly about Binge-Eating Disorder (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Binge-Eating Disorder studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
136
Recruiting
35
Status unknown
19
Not yet recruiting
14
Active, not recruiting
13
Terminated
6

Phase

Phase 2
36
Phase 3
32
Phase 1
11
Phase 4
5

Where

United States
122
France
15
Canada
13
United Kingdom
11
Germany
9
Italy
8

Who runs them

Yale University (15) · Lindner Center of HOPE (11) · University of North Carolina, Chapel Hill (9) · Drexel University (9) · King's College London (6) · Shire (6) · University of Louisville (5) · New York State Psychiatric Institute (5)

What is being tested here

Drugs under test in Binge-Eating Disorder studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Solriamfetol223
Prebiotics101
Tirzepatide101
Oxytocin101
Lisdexamfetamine079
Dasotraline034
Bupropion023
Topiramate023
Naltrexone012
Prazosin002

Drug classes tested here GLP-1 receptor agonists 1 open · Stimulants 11 · Opioid antagonists 4

Coming up

2phase 3 studies under way
20studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 35 Binge-Eating Disorder studies recruiting now, 8 (23%) set no upper age limit and 24 (69%) stop at 75 or younger. 10 (29%) take children under 18. 3 (9%) are for women only and 0 (0%) for men only; 4 (11%) take healthy volunteers.

Recruiting studies that take each age, of 35
AgeWomenMen
101 (3%)1 (3%)
1832 (91%)29 (83%)
3031 (89%)28 (80%)
4030 (86%)27 (77%)
5030 (86%)27 (77%)
6526 (74%)24 (69%)
7511 (31%)11 (31%)
8510 (29%)10 (29%)

Across all 233 studies, recruiting or not: 72% stop at 75 or younger and 65% at 65; 20% take children; 16% are for women only and 0% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Binge-Eating Disorder studies take

Of 89 interventional studies with no phase under Binge-Eating Disorder, half reached primary completion within 25 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase25 mo16–53 · 89 studies—34 mo16–53 · 84 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 233. Browse all 233 → or search them.